Aptevo Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aptevo Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Aptevo Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $149K, a 67.3% decline year-over-year.
  • Aptevo Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.5M, a 31.6% decline year-over-year.
  • Aptevo Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.19M, a 21.7% increase from 2022.
  • Aptevo Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.8M, a 9.68% increase from 2021.
  • Aptevo Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.64M, a 30.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.19M +$391K +21.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $1.8M +$159K +9.68% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $1.64M +$388K +30.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.26M -$343K -21.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $1.6M -$542K -25.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $2.14M -$2.74M -56.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-25
2017 $4.88M +$1.08M +28.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $3.81M +$2.7M +244% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-13
2015 $1.11M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.